Search results

Evidence-based recommendations on abrocitinib (Cibinqo), tralokinumab (Adtralza) or upadacitinib (Rinvoq) for treating moderate to severe atopic dermatitis.

Result type

Technology appraisal guidance

Published

3 August 2022

Evidence-based recommendations on pembrolizumab (Keytruda) for the adjuvant treatment of resected stage 2B and 2C melanoma in people 12 years and over.

Result type

Technology appraisal guidance

Published

26 October 2022

Evidence-based recommendations on gilteritinib (Xospata) for relapsed or refractory FLT3-mutation-positive acute myeloid leukaemia in adults.

Result type

Technology appraisal guidance

Published

12 August 2020

Evidence-based recommendations on upadacitinib (Rinvoq) for previously treated moderately to severely active Crohn’s disease in adults.

Result type

Technology appraisal guidance

Published

21 June 2023

Evidence-based recommendations on risankizumab (Skyrizi) for treating active psoriatic arthritis in adults.

Result type

Technology appraisal guidance

Published

13 July 2022

Evidence-based recommendations on mepolizumab (Nucala) for treating severe eosinophilic asthma in adults.

Result type

Technology appraisal guidance

Published

3 February 2021

Evidence-based recommendations on encorafenib (Braftovi) with binimetinib (Mektovi) for treating unresectable or metastatic BRAF V600 mutation-positive melanoma in adults.

Result type

Technology appraisal guidance

Published

27 February 2019

This guideline covers supporting the social and emotional wellbeing of vulnerable children under 5 through home visiting, childcare and early education. It aims to optimise care for young children who need extra support because they have or are at risk of social or emotional problems.

Result type

Public health guideline

Published

24 October 2012

This guideline covers rehabilitation strategies for adults who have experienced a critical illness and stayed in critical care. It aims to improve physical, psychological and cognitive outcomes in people who have been discharged from critical care.

Result type

Clinical guideline

Published

25 March 2009

problems, but although some people get them, many people do not. We also do not know how many people would have had those problems even...

This quality standard covers assessing if people need help with their medicines and deciding what medicines support is needed to enable people to manage their medicines. It also includes communication between health and social care staff, to ensure people have the medicines support they need. It describes high-quality care in priority areas for improvement.

Result type

Quality standard

Published

24 July 2018

Evidence-based recommendations on VA ECMO for extracorporeal cardiopulmonary resuscitation (ECPR) in adults with refractory cardiac arrest. This involves using an artificial lung to oxygenate the blood outside the body.

Result type

HealthTech guidance

Published

22 October 2025

We offer a dedicated training opportunity towards achieving competency in either Faculty of Public Health Specialty Training curriculum outcomes.

This guideline covers keeping adults in care homes safe from abuse and neglect. It includes potential indicators of abuse and neglect by individuals or organisations, and covers the safeguarding process from when a concern is first identified through to section 42 safeguarding enquiries. There are recommendations on policy, training, and care home culture, to improve care home staff awareness of safeguarding and ensure people can report concerns when needed.

Result type

NICE guideline

Published

26 February 2021

This quality standard covers the additional antenatal care for women who are pregnant with twins or triplets that is offered alongside routine antenatal care. It describes high-quality care in priority areas for improvement.

Result type

Quality standard

Last updated

4 September 2019